# Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules

> **NCT02680132** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nexium 40 mg DR Capsules of AstraZeneca LP, USA
- **DRUG:** Torrent's Esomeprazole Magnesium DR Capsules 40 mg

## Key facts

- **NCT ID:** NCT02680132
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680132, "Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02680132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*